X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Panacea Biotech with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs IPCA LABS - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH IPCA LABS PANACEA BIOTECH/
IPCA LABS
 
P/E (TTM) x 84.9 27.7 306.1% View Chart
P/BV x 1.9 2.1 88.7% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 PANACEA BIOTECH   IPCA LABS
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
IPCA LABS
Mar-17
PANACEA BIOTECH/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs149643 23.1%   
Low Rs82503 16.4%   
Sales per share (Unadj.) Rs84.1254.4 33.1%  
Earnings per share (Unadj.) Rs-18.316.1 -113.9%  
Cash flow per share (Unadj.) Rs-6.729.8 -22.5%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs83.7194.6 43.0%  
Shares outstanding (eoy) m61.25126.20 48.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.42.3 61.0%   
Avg P/E ratio x-6.335.7 -17.7%  
P/CF ratio (eoy) x-17.219.2 -89.6%  
Price / Book Value ratio x1.42.9 46.9%  
Dividend payout %06.2 0.0%   
Avg Mkt Cap Rs m7,07472,300 9.8%   
No. of employees `0002.813.3 20.7%   
Total wages/salary Rs m1,4496,960 20.8%   
Avg. sales/employee Rs Th1,874.12,413.5 77.7%   
Avg. wages/employee Rs Th527.0523.2 100.7%   
Avg. net profit/employee Rs Th-407.7152.4 -267.5%   
INCOME DATA
Net Sales Rs m5,15432,106 16.1%  
Other income Rs m100226 44.2%   
Total revenues Rs m5,25432,332 16.2%   
Gross profit Rs m-7664,448 -17.2%  
Depreciation Rs m7111,730 41.1%   
Interest Rs m1,503241 624.2%   
Profit before tax Rs m-2,8812,703 -106.6%   
Minority Interest Rs m110-   
Prior Period Items Rs m-60-   
Extraordinary Inc (Exp) Rs m1,7710-   
Tax Rs m17675 2.5%   
Profit after tax Rs m-1,1212,028 -55.3%  
Gross profit margin %-14.913.9 -107.3%  
Effective tax rate %-0.625.0 -2.3%   
Net profit margin %-21.86.3 -344.5%  
BALANCE SHEET DATA
Current assets Rs m3,81017,340 22.0%   
Current liabilities Rs m8,3659,559 87.5%   
Net working cap to sales %-88.424.2 -364.7%  
Current ratio x0.51.8 25.1%  
Inventory Days Days156100 155.2%  
Debtors Days Days6757 118.2%  
Net fixed assets Rs m14,48020,779 69.7%   
Share capital Rs m61252 24.3%   
"Free" reserves Rs m90324,499 3.7%   
Net worth Rs m5,12724,553 20.9%   
Long term debt Rs m5,8323,517 165.8%   
Total assets Rs m19,43339,595 49.1%  
Interest coverage x-0.912.2 -7.5%   
Debt to equity ratio x1.10.1 793.9%  
Sales to assets ratio x0.30.8 32.7%   
Return on assets %2.05.7 34.3%  
Return on equity %-21.98.3 -264.8%  
Return on capital %3.610.5 34.7%  
Exports to sales %24.548.6 50.4%   
Imports to sales %10.214.2 71.5%   
Exports (fob) Rs m1,26415,617 8.1%   
Imports (cif) Rs m5254,571 11.5%   
Fx inflow Rs m1,53915,617 9.9%   
Fx outflow Rs m9425,828 16.2%   
Net fx Rs m5979,790 6.1%   
CASH FLOW
From Operations Rs m5992,764 21.7%  
From Investments Rs m-438-1,432 30.6%  
From Financial Activity Rs m-303-1,591 19.0%  
Net Cashflow Rs m-141-259 54.6%  

Share Holding

Indian Promoters % 74.5 45.9 162.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 11.4 5.3%  
FIIs % 1.3 25.3 5.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 17.4 135.6%  
Shareholders   10,259 36,892 27.8%  
Pledged promoter(s) holding % 35.1 2.1 1,638.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   PFIZER  GSK PHARMA  PLETHICO PHARMA  DR. REDDYS LAB  ABBOTT INDIA  

Compare PANACEA BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Infosys Down 4.1%(09:30 am)

Asian stock markets opened mixed in early trade today. Hong Kong Hang Seng has advanced 143 points and China's Shanghai Composite has gained 9 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Aug 21, 2017 10:11 AM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS